DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

References

Walter HS, Rule SA, Dyer MJ. , et al.
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies.

Blood 2016;
127 (04) 411-419

Download Bibliographical Data

Access:
Access: